Pages

Sunday, June 9, 2019

Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial - The Lancet

Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial  The Lancet
Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial - The Lancet
Read More
Posted by at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)